Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adicet Bio, Inc. Director's Dealing 2021

May 21, 2021

34412_dirs_2021-05-20_c8cedd04-1720-4ef5-b100-7ee035a407a7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-05-18

Reporting Person: Jakobovits Aya (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-18 Common Stock S 3108 $14.0527 Disposed 218699 Indirect
2021-05-18 Common Stock S 3100 $14.0558 Disposed 218706 Indirect
2021-05-20 Common Stock S 892 $14.2291 Disposed 217807 Indirect
2021-05-20 Common Stock S 900 $14.228 Disposed 217806 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 329199 Indirect
Common Stock 135799 Indirect

Footnotes

F1: These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: Shares held in a trust of which Dr. Jakobovits spouse is the trustee and Dr. Jakobovits child is the beneficiary.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: Shares held in a trust of which Dr. Jakobovits spouse is the trustee and Dr. Jakobovits child is the beneficiary.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.47. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F8: Shares held in a grantor retained annuity trust ("GRAT") of which Dr. Jakobovits spouse is the trustee and Dr. Jakobovits is the sole annuitant and current beneficiary.

F9: Shares held in a GRAT of which Dr. Jakobovits spouse is the trustee and Dr. Jakobovits is the sole annuitant and current beneficiary.